Literature DB >> 15615646

Tau phosphorylation: physiological and pathological consequences.

William H Stoothoff1, Gail V W Johnson.   

Abstract

The microtubule-associated protein tau, abundant in neurons, has gained notoriety due to the fact that it is deposited in cells as fibrillar lesions in numerous neurodegenerative diseases, and most notably Alzheimer's disease. Regulation of microtubule dynamics is the most well-recognized function of tau, but it is becoming increasingly evident that tau plays additional roles in the cell. The functions of tau are regulated by site-specific phosphorylation events, which if dysregulated, as they are in the disease state, result in tau dysfunction and mislocalization, which is potentially followed by tau polymerization, neuronal dysfunction and death. Given the increasing evidence that a disruption in the normal phosphorylation state of tau plays a key role in the pathogenic events that occur in Alzheimer's disease and other neurodegenerative conditions, it is of crucial importance that the protein kinases and phosphatases that regulate tau phosphorylation in vivo as well as the signaling cascades that regulate them be identified. This review focuses on recent literature pertaining to the regulation of tau phosphorylation and function in cell culture and animal model systems, and the role that a dysregulation of tau phosphorylation may play in the neuronal dysfunction and death that occur in neurodegenerative diseases that have tau pathology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15615646     DOI: 10.1016/j.bbadis.2004.06.017

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  145 in total

1.  AVR/NAVR deficiency lowers blood pressure and differentially affects urinary concentrating ability, cognition, and anxiety-like behavior in male and female mice.

Authors:  Victoria L M Herrera; Pia Bagamasbad; Julius L Decano; Nelson Ruiz-Opazo
Journal:  Physiol Genomics       Date:  2010-10-05       Impact factor: 3.107

Review 2.  Are tangles as toxic as they look?

Authors:  Tara L Spires-Jones; Katherine J Kopeikina; Robert M Koffie; Alix de Calignon; Bradley T Hyman
Journal:  J Mol Neurosci       Date:  2011-06-03       Impact factor: 3.444

3.  Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects.

Authors:  Fabio Di Domenico; Rukhsana Sultana; Eugenio Barone; Marzia Perluigi; Chiara Cini; Cesare Mancuso; Jian Cai; William M Pierce; D Allan Butterfield
Journal:  J Proteomics       Date:  2011-04-13       Impact factor: 4.044

4.  NMNAT suppresses tau-induced neurodegeneration by promoting clearance of hyperphosphorylated tau oligomers in a Drosophila model of tauopathy.

Authors:  Yousuf O Ali; Kai Ruan; R Grace Zhai
Journal:  Hum Mol Genet       Date:  2011-09-30       Impact factor: 6.150

Review 5.  GSK3 signalling in neural development.

Authors:  Eun-Mi Hur; Feng-Quan Zhou
Journal:  Nat Rev Neurosci       Date:  2010-08       Impact factor: 34.870

6.  A multiplexed proteomics approach to differentiate neurite outgrowth patterns.

Authors:  Tong Liu; Veera D'mello; Longwen Deng; Jun Hu; Michael Ricardo; Sanqiang Pan; Xiaodong Lu; Scott Wadsworth; John Siekierka; Raymond Birge; Hong Li
Journal:  J Neurosci Methods       Date:  2006-06-23       Impact factor: 2.390

7.  Modification of lipid rafts by extracellular vesicles carrying HIV-1 protein Nef induces redistribution of amyloid precursor protein and Tau, causing neuronal dysfunction.

Authors:  Michael Ditiatkovski; Nigora Mukhamedova; Dragana Dragoljevic; Anh Hoang; Hann Low; Tatiana Pushkarsky; Ying Fu; Irena Carmichael; Andrew F Hill; Andrew J Murphy; Michael Bukrinsky; Dmitri Sviridov
Journal:  J Biol Chem       Date:  2020-07-30       Impact factor: 5.157

8.  Multiple mechanisms of extracellular tau spreading in a non-transgenic tauopathy model.

Authors:  Meghan N Le; Wonhee Kim; Sangmook Lee; Ann C McKee; Garth F Hall
Journal:  Am J Neurodegener Dis       Date:  2012-11-25

9.  Nitrosylation of GAPDH augments pathological tau acetylation upon exposure to amyloid-β.

Authors:  Tanusree Sen; Pampa Saha; Nilkantha Sen
Journal:  Sci Signal       Date:  2018-03-20       Impact factor: 8.192

10.  Blockade of Tau hyperphosphorylation and Aβ₁₋₄₂ generation by the aminotetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic and σ₁ receptor agonist, in a nontransgenic mouse model of Alzheimer's disease.

Authors:  Valentine Lahmy; Johann Meunier; Susanna Malmström; Gaelle Naert; Laurent Givalois; Seung Hyun Kim; Vanessa Villard; Alexandre Vamvakides; Tangui Maurice
Journal:  Neuropsychopharmacology       Date:  2013-03-14       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.